Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

Proliferative Phase

Proliferative Phase

The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...

Uterine Tubes

Uterine Tubes

The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Appearance of levator ani muscle subdivision defects on level III vaginal support structures in women with and without pelvic organ prolapse: an MRI study.

International urogynecology journal·2023

Same author

A model for predicting unscheduled caesarean section in nulliparae.

Ceska gynekologie·2021

Same author

Laboratory options for risk assessment of pregnancy pathologies.

Physiological research·2020

Same author

First-trimester screening for preeclampsia.

Ceska gynekologie·2019

Same author

[MRI analysis of the musculo-fascial component of pelvic floor in woman before planned vaginal reconstruction procedur for symptomatic pelvic organ prolapse].

Ceska gynekologie·2018

Same author

[The hypercholesterolemias in pregnancy: their etiology and diagnostic significance considerations].

Ceska gynekologie·2018

Search research articles

Related Experiment Video

Updated: May 25, 2026

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Published on: June 12, 2020

[Quiscent trophoblastic disease].

F Hron¹, V Hejda, J Feyereisl

¹Centrum pro trofoblastickou nemoc v CR, Praha, Ustav pro péci o matku a díte, Praha.

Ceska Gynekologie

|February 9, 2012

Summary

This summary is machine-generated.

Quiescent trophoblastic disease, characterized by low hCG levels, can transform into malignant forms. Early detection and management are crucial for successful outcomes in these rare cases.

More Related Videos

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Published on: January 8, 2012

Related Experiment Videos

Last Updated: May 25, 2026

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Published on: June 12, 2020

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Published on: January 8, 2012

Area of Science:

Gynecology
Oncology
Reproductive Endocrinology

Background:

Quiescent trophoblastic disease is a recently described clinical entity.
It is defined by persistent low levels of human chorionic gonadotropin (hCG) without evidence of active trophoblastic tumor.
This condition poses a significant risk for malignant transformation.

Observation:

A case report details a 27-year-old primigravida with a history of molar pregnancy.
The patient presented with persistently low serum hCG levels for over 18 months post-termination.
Malignant transformation occurred, marked by a rapid rise in hCG, necessitating chemotherapy.

Findings:

The case illustrates the potential for dormant trophoblastic disease to undergo malignant progression.
Successful chemotherapy was completed following the diagnosis of malignant transformation.

Implications:

This case highlights the importance of monitoring low hCG levels for extended periods.
Recognizing quiescent trophoblastic disease is critical for timely intervention and preventing advanced malignancy.
Further research into the mechanisms and optimal management of quiescent trophoblastic disease is warranted.